1.
Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trial.
Konstas Anastasios-Georgios, Boboridis Konstadinos G, Athanasopoulos Georgios P, Haidich Anna-Bettina, Voudouragkaki Irini C, Pagkalidou Eirini et al.
Eye (Lond)May 20239 citationsRandomized Controlled Trial
Switching to preservative-free glaucoma drops improved ocular surface disease (OSD) and IOP control, with added cyclosporine 0.1% further reversing OSD, benefiting patients on long-term therapy.